Witte, Desiree <br/><br/>
Safety and Immunogenicity of Seven Dosing Regimens of the Candidate RTS,S/AS01E Malaria Vaccine Integrated Within an Expanded Program on Immunization Regimen: A Phase II, Single-Center, Open, Controlled Trial in Infants in Malawi.  [electronic resource] 

 -  The Pediatric infectious disease journal  05 2018 
 - 483-491 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-0987 
<br/><br/><label>Standard No.: </label>10.1097/INF.0000000000001937  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Protozoan--blood<br/>Female<br/>Fever--etiology<br/>Humans<br/>Immunization Programs<br/>Immunization Schedule<br/>Immunogenicity, Vaccine<br/>Infant, Newborn<br/>Malaria Vaccines--administration & dosage<br/>Malaria, Falciparum--prevention & control<br/>Malawi<br/>Male<br/>Plasmodium falciparum--immunology<br/>Vaccination--adverse effects